Uptake and Tolerance of Chemotherapy in Elderly Patients with Small Cell Lung Cancer and Impact on Survival

Table 4

Reasons for dose reduction and not completing chemotherapy.

	Reasons for dose reduction^1	Reasons for incomplete chemotherapy cycles^1
	𝑁 (%)^2	𝑁 (%)^2
Total	40 (100)	56 (100)
Hematological toxicity	30 (75)	32 (56)
Nonhematological toxicity	3 (8)	19 (34)
Frailty/performance status	10 (25)	25 (44)
Other medical reason	5 (13)	13 (25)
Patients’ decision	0 (—)	2 (4)
Unclear	6 (15)	8 (14)

1Multiple reasons are possible; therefore, the sum of the reasons exceeds the total in each column.
²Column percentage.